Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial: Correction.
Journal: Obstetrics and gynecology
Published: July 16, 2026
Efficacy and safety outcomes from the MATISSE phase 3 trial of maternal bivalent RSVpreF vaccination among pregnant women vaccinated at 32 to 36 weeks of gestation.
Journal: Swiss medical weekly
Published: April 10, 2026
Maternal and Newborn Group B Streptococcus Serology in the United States and South Africa.
Journal: Open forum infectious diseases
Published: January 15, 2026
Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds.
Journal: Vaccines
Published: December 09, 2025
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study.
Journal: EClinicalMedicine
Published: August 13, 2025
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine: Correction.
Journal: Obstetrics and gynecology
Published: May 15, 2025
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.
Journal: Obstetrics and gynecology
Published: September 18, 2024
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial.
Journal: Obstetrics and gynecology
Published: September 17, 2024
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
Journal: The New England journal of medicine
Published: April 05, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
Journal: The New England journal of medicine
Published: February 15, 2023
Last Updated: 09/26/2026